Compare Strategy Inc. (MSTR) vs Zimmer Biomet Holdings Inc (ZBH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Strategy Inc. vs Zimmer Biomet Holdings Inc — how do they compare? Strategy Inc. trades at $101.91 (market cap $35.47B), while Zimmer Biomet Holdings Inc trades at $90.03 (market cap $17.36B). The key difference: Strategy Inc. is far larger — about 2× Zimmer Biomet Holdings Inc's market cap, and Zimmer Biomet Holdings Inc pays a 1.07% dividend while Strategy Inc. pays none. Which is the better fit depends on your goals.
| MSTR | ZBH | |
|---|---|---|
Market Cap | $35.47B | $17.36B |
Sector | Technology | Health |
52-Week High | $426.40 | $107.71 |
52-Week Low | $82.31 | $79.58 |
Enterprise Value | $50.50B | $24.40B |
Dividend Yield | — | 1.07% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Strategy Inc.
MicroStrategy Inc is a provider of enterprise analytics and mobility software. It offers MicroStrategy Analytics platform that delivers reports and dashboards and enables users to conduct ad hoc analysis and share insights through mobile devices or the Web
Read more on MSTR →About Zimmer Biomet Holdings Inc
Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants, as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly 70% of total revenue is derived from sales of large joints, another quarter comes from extremities, trauma, and related surgical products.
Read more on ZBH →
